Duricef en es it fr

Duricef Brand names, Duricef Analogs

Duricef Brand Names Mixture

  • None

Duricef Chemical_Formula

C16H17N3O5S

Duricef RX_link

http://www.rxlist.com/cgi/generic/cefadrox.htm

Duricef fda sheet

Duricef msds (material safety sheet)

Duricef Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Duricef Molecular Weight

363.389 g/mol

Duricef Melting Point

197oC

Duricef H2O Solubility

1110 mg/L

Duricef State

Solid

Duricef LogP

-0.355

Duricef Dosage Forms

Capsule; Tablet; Oral liquid

Duricef Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Duricef Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Duricef Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Duricef side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Duricef Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Duricef Organisms Affected

Enteric bacteria and other eubacteria